Work

Supplementary Table 3 from Expression of AR-V7 and ARv567es in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY

Year: 2023
Type: supplementary-materials
Abstract: Copy number for AR-V7 and ARv567es stratified by PSA response AR, androgen receptor; IQ, interquartile; PSA50, 50% reduction from baseline in prostate-specific antigen; SD, standard deviation.
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361817208
Cites:
Cited by:
Related to: 10